Johnson & Johnson Common Stock (JNJ): PT Raised News

JNJ – Morgan Stanley raises PT to $135 from $130. This new price target represents a 6.32% upside over the stock’s previous closing price of $126.97.


Update: As of May. 22, 2017, this bullish analyst call has returned 0.23%.


Key Facts Surrounding This News Item


  • JNJ had a POWR Rating of A (Strong Buy) coming into today.
  • JNJ was 1.74% above its 10-Day Moving Average coming into today.
  • JNJ was 2.35% above its 20-Day Moving Average coming into today.
  • JNJ was 1.66% above its 50-Day Moving Average coming into today.
  • JNJ was 5.39% above its 100-Day Moving Average coming into today.
  • JNJ was 7.43% above its 200-Day Moving Average coming into today.
  • JNJ had returned +10.94% year-to-date leading up to today’s news, versus a +6.38% return from the benchmark S&P 500 during the same period.

More Info About Johnson & Johnson Common Stock (JNJ)


Johnson & Johnson researches and develops, manufactures, and sells various products in the health-care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. Some of its well-known brands include Tylenol-fever, Listerine-bad breath, Splenda-no-calorie sweetener, Neutrogena-skin care, Pepcid-heartburn, Zyrtec – allergy, Motrin-ibuprofen, Sudafed-allergy, and plenty more. The company was founded in 1885 and is based in New Brunswick, New Jersey. View our full JNJ ticker page with ratings, news, and more.

JNJ at a Glance

JNJ Current POWR Rating™
Overall POWR Rating™
JNJ Current Price $127.26 0.20%
More JNJ Ratings, Data, and News

JNJ Price Reaction

The day of this event (May. 19, 2017)
JNJ Closing Price$127.00 0.02%
JNJ Volume6,957,100
2.29% from avg
Leading up to this event
JNJ 1-mo return4.61%
After this event
JNJ 1-day return0.23%

JNJ Price Chart

More Johnson & Johnson Common Stock (JNJ) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JNJ News
Page generated in 0.6874 seconds.